Rain Oncology Inc. Common Stock
RAIN
RAIN was delisted on the 25th of January, 2024.
58 hedge funds and large institutions have $20.4M invested in Rain Oncology Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 9 closing their positions.
109% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 11
46% more capital invested
Capital invested by funds: $13.9M → $20.4M (+$6.44M)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
2% more funds holding
Funds holding: 57 → 58 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$1.38M |
| 2 |
DAM
Deltec Asset Management
New York
|
+$404K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$119K |
| 4 |
BlackRock
New York
|
+$81.3K |
| 5 |
Morgan Stanley
New York
|
+$80.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$524K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$400K |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$280K |
| 4 |
Two Sigma Investments
New York
|
-$81.5K |
| 5 |
Two Sigma Advisers
New York
|
-$64.5K |
RAIN Hedge Fund Activity: Q4 2023 in Review
58 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q4 2023, worth a combined $20.4M — up 46% from $13.9M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new RAIN positions and 9 closed out — a net gain of 1 holder — while 23 added to existing stakes and 11 trimmed.
The largest buyer was BML Capital Management, adding an estimated $1.38M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $524K sold.
- 58 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q4 2023, up from 57 in Q3 2023.
- Funds reported $20.4M of Rain Oncology Inc. Common Stock stock for Q4 2023, up 46% quarter-over-quarter.
- 10 funds opened new Rain Oncology Inc. Common Stock positions in Q4 2023 and 9 closed out, a net change of +1 holder.
- The largest Rain Oncology Inc. Common Stock buyer in Q4 2023 was BML Capital Management, an estimated $1.38M added.
- The largest Rain Oncology Inc. Common Stock seller in Q4 2023 was Acadian Asset Management, an estimated $524K sold.
Based on aggregated 13F filings for Q4 2023.